Can-Fite BioPharma Rings The Opening Bell at NYSE

Can-Fite Biopharma Ltd - $CANF |

On Dec. 5, Can-Fite BioPharma (CANF)  celebrated rang the Opening Bell at the New York Stock Exchange to celebrate the Petach Tikva, Israel-based company's recent listing on the NYSE MKT. CEO Dr. Pnina Fishman was joined by key members of the company's management team and their guests for the momentous ceremony. Can-Fite is a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases. Be sure to read Equities.com's interview with Dr. Fishman here to learn more about Can-Fite's strategic focus and goals going forward.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel) 2.14 0.02 0.94 6,700
BMQCF Bank of Montreal Non Cumulative 5-Year Rate Reset n/a n/a n/a 0

Comments

Emerging Growth

IBC Advanced Alloys Corp.

IBC Advanced Alloys Corp is engaged in the production and development of specialty alloy products. Its products include copper alloys and berryllium aluminium alloys.

Private Markets

Pinterest

Pinterest is a visual discovery and planning tool. Users ("Pinners") use the site and apps to get ideas for their future, such as recipes, places to travel, and products to…

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.